GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Adicon Holdings Ltd (OTCPK:ADCNF) » Definitions » Research & Development

Adicon Holdings (Adicon Holdings) Research & Development : $21.5 Mil (TTM As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Adicon Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Adicon Holdings's Research & Development for the three months ended in Dec. 2023 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $21.5 Mil.

Adicon Holdings Research & Development Historical Data

The historical data trend for Adicon Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adicon Holdings Research & Development Chart

Adicon Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Research & Development
15.60 19.70 23.34 20.10

Adicon Holdings Quarterly Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial - 11.95 11.87 9.64 -

Adicon Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $21.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adicon Holdings  (OTCPK:ADCNF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Adicon Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Adicon Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Adicon Holdings (Adicon Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Adicon Holdings Ltd (OTCPK:ADCNF) » Definitions » Research & Development
Comparable Companies
Traded in Other Exchanges
09860:Hong Kong
Address
No. 208, Zhenzhong Road, West Lake, Zhejiang, Hangzhou, CHN
Website
https://www.adicon.com.cn
Adicon Holdings Ltd is one of the top three independent clinical laboratory or ICL, service providers in China. The company offers comprehensive and best-in-class testing services primarily to hospitals and health check centers through an integrated network of 33 self-operated laboratories across China. The high quality of its services is backed by its strong performance in terms of international accreditation and comprehensive testing menu. Its testing portfolio consists of over 4,000 medical diagnostic tests, including over 1,700 routine tests and over 2,300 esoteric tests. It has three major service platforms. Among them, the inspection service platform consists of clinical, pathology, reproductive genetic, genetic, and mass spectrometry laboratories.

Adicon Holdings (Adicon Holdings) Headlines

No Headlines